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Background
We aim to report our data on the efficacy and safety of
using an optimally invasive sternum-sparing approach to
MV surgery.
Methods
Between April 2007 and December 2012, we used a ster-
num-sparing but optimally invasive approach to MV sur-
gery on 99 patients (mean age 60.71 ± 12.9 years) with
mean preoperative EF and LVEDD of 53.8 ± 11.4 % and
56.13 ± 6.9 mm, respectively. Twenty seven patients had
previous coronary artery bypass and MV surgeries. All
patients had severe mitral insufficiency (MI) from chor-
dal rupture; prolapse of the anterior leaflet, paravalvular
leak, endocarditis, floppy MV, and from previous MV
surgery. The optimally invasive approach was a right-
sided anterolateral thoracotomy at the 5th intercostal
space with an approximately 10 cm skin incision. Cardio-
pulmonary bypass (CPB) was through either cannulation
of the ascending aorta or femoral artery with direct bica-
val cannulation. Modified Gerbode-Hetzer plication for
ruptured chordae and modified Paneth-Hetzer posterior
annulus shortening annuloplasty, for annulus dilatation
or leaflet prolapse were employed. Paravalvular leaks
were closed. Intraoperative TEE was used to evaluate the
adequacy of repair or replacement.
Results
The mean CPB and cross-clamp time were 134.4 ± 52.2
and 56.63 ± 29.7 minutes, respectively. All patients were
discharged with either absence or minimal MI. Mean
postoperative EF improved to 65.13 ± 8.7% while mean
postoperative LVEDD decreased to 51.6 ± 7.0 mm.
Sixty-seven percent of patients were extubated within
24 hours, 86% required minimal postoperative analgesia
and all had satisfactory functional results on follow-up
(mean 4.2 ± 1.07 years) aside from good cosmesis. Free-
dom of reoperation is 100% until the last follow-up.
Conclusions
This new innovative approach is a safe and effective option
to MV surgery, reduces surgical trauma, increases patients’
functional capacity and satisfaction, no morbidity, with
100% freedom from reoperation in 4 years.
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